Literature DB >> 10231442

High water intake ameliorates tubulointerstitial injury in rats with subtotal nephrectomy: possible role of TGF-beta.

T Sugiura1, A Yamauchi, H Kitamura, Y Matsuoka, M Horio, E Imai, M Hori.   

Abstract

BACKGROUND: It has been shown that tubulointerstitial injury correlates well with a decline of renal function. In this study, we investigated the effect of high water intake (HWI) on functional and structural parameters in rats with subtotal nephrectomy.
METHODS: Two weeks after the ablative procedure, rats were divided into two groups. One group received the treatment with HWI (3% sucrose added to drinking water) for eight weeks. Functional parameters were compared with sham-operated control (CONT) or nephrectomized rats without treatment (NX). Remnant kidneys were then assessed histologically for evidence of interstitial fibrosis and glomerulosclerosis.
RESULTS: Creatinine clearance was significantly improved in HWI rats compared with NX rats. Simultaneously, urinary protein was also significantly reduced in HWI rats. HWI predominantly ameliorated interstitial lesions and, to a lesser extent, glomerular lesions. Northern blot analysis demonstrated that transforming growth factor-beta (TGF-beta) mRNA expression was significantly suppressed in HWI rats. In situ hybridization revealed that HWI suppressed TGF-beta mRNA expression mainly in the outer medulla. Fibronectin mRNA was also reduced by the HWI treatment. The changes in TGF-beta and fibronectin mRNA were in parallel with Na+/myo-inositol cotransporter (SMIT) mRNA, which is regulated by extracellular osmolarity. Immunohistochemistry demonstrated that protein expression of TGF-beta and fibronectin coincided with the mRNA expression.
CONCLUSION: These results suggest that HWI reduces TGF-beta mRNA expression in medullary interstitium and ameliorates tubulointerstitial injury in rats with reduced renal mass.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10231442     DOI: 10.1046/j.1523-1755.1999.00443.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  24 in total

1.  Urine volume and change in estimated GFR in a community-based cohort study.

Authors:  William F Clark; Jessica M Sontrop; Jennifer J Macnab; Rita S Suri; Louise Moist; Marina Salvadori; Amit X Garg
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 8.237

Review 2.  Vasopressin: a novel target for the prevention and retardation of kidney disease?

Authors:  Lise Bankir; Nadine Bouby; Eberhard Ritz
Journal:  Nat Rev Nephrol       Date:  2013-02-26       Impact factor: 28.314

3.  Plasma copeptin and chronic kidney disease risk in 3 European cohorts from the general population.

Authors:  Ray El Boustany; Irina Tasevska; Esther Meijer; Lyanne M Kieneker; Sofia Enhörning; Guillaume Lefèvre; Kamel Mohammedi; Michel Marre; Frédéric Fumeron; Beverley Balkau; Nadine Bouby; Lise Bankir; Stephan Jl Bakker; Ronan Roussel; Olle Melander; Ron T Gansevoort; Gilberto Velho
Journal:  JCI Insight       Date:  2018-07-12

Review 4.  Effects of dietary interventions on incidence and progression of CKD.

Authors:  Nishank Jain; Robert F Reilly
Journal:  Nat Rev Nephrol       Date:  2014-10-21       Impact factor: 28.314

Review 5.  Water intake keeps type 2 diabetes away? Focus on copeptin.

Authors:  Giovanna Muscogiuri; Luigi Barrea; Giuseppe Annunziata; Martina Vecchiarini; Francesco Orio; Carolina Di Somma; Annamaria Colao; Silvia Savastano
Journal:  Endocrine       Date:  2018-07-19       Impact factor: 3.633

6.  Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease.

Authors:  Esther Meijer; Stephan J L Bakker; Eric J van der Jagt; Gerjan Navis; Paul E de Jong; Joachim Struck; Ron T Gansevoort
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-07       Impact factor: 8.237

7.  Vasopressin in chronic kidney disease: an elephant in the room?

Authors:  Vicente E Torres
Journal:  Kidney Int       Date:  2009-11       Impact factor: 10.612

Review 8.  Vasopressin antagonists in polycystic kidney disease.

Authors:  Vicente E Torres
Journal:  Semin Nephrol       Date:  2008-05       Impact factor: 5.299

9.  Keishibukuryogan reduces renal injury in the early stage of renal failure in the remnant kidney model.

Authors:  Takako Nakagawa; Izumi Tashiro; Makoto Fujimoto; Michiko Jo; Shinya Sakai; Hiroshi Oka; Hirozo Goto; Yutaka Shimada; Naotoshi Shibahara
Journal:  Evid Based Complement Alternat Med       Date:  2011-05-03       Impact factor: 2.629

10.  Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31).

Authors:  Ineke J Riphagen; Wendy E Boertien; Alaa Alkhalaf; Nanne Kleefstra; Ron T Gansevoort; Klaas H Groenier; Kornelis J J van Hateren; Joachim Struck; Gerjan Navis; Henk J G Bilo; Stephan J L Bakker
Journal:  Diabetes Care       Date:  2013-06-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.